Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?
Main Author: | Ralf Weiskirchen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2020.01905/full |
Similar Items
-
The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report
by: Igor N. Banin, et al.
Published: (2021-06-01) -
Assessment of pulmonary surfactant in COVID-19 patients
by: Peter Schousboe, et al.
Published: (2020-09-01) -
The Impact of Ambient Air Pollution Toward Coronavirus Disease 2019 (Covid19): A Literature Review
by: Lulukatin Nasikhah, et al.
Published: (2020-09-01) -
The role of surfactant in asthma
by: Hohlfeld Jens
Published: (2002-01-01) -
Is Body Mass Index A Risk Factor in the Clinical Course of Patients with Coronavirus Disease 2019 Pneumonia?
by: Demet Turan, et al.
Published: (2021-01-01)